EDURANT - 59676-278-01 - (rilpivirine hydrochloride)

Alphabetical Index


Drug Information of EDURANT

Product NDC: 59676-278
Proprietary Name: EDURANT
Non Proprietary Name: rilpivirine hydrochloride
Active Ingredient(s): 25    mg/1 & nbsp;   rilpivirine hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of EDURANT

Product NDC: 59676-278
Labeler Name: Janssen Products, LP
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA202022
Marketing Category: NDA
Start Marketing Date: 20110520

Package Information of EDURANT

Package NDC: 59676-278-01
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (59676-278-01)

NDC Information of EDURANT

NDC Code 59676-278-01
Proprietary Name EDURANT
Package Description 30 TABLET, FILM COATED in 1 BOTTLE (59676-278-01)
Product NDC 59676-278
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name rilpivirine hydrochloride
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20110520
Marketing Category Name NDA
Labeler Name Janssen Products, LP
Substance Name RILPIVIRINE HYDROCHLORIDE
Strength Number 25
Strength Unit mg/1
Pharmaceutical Classes Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Non-Nucleoside Analog [Chemical/Ingredient]

Complete Information of EDURANT


General Information